Form 4 Filing for Camp4 Therapeutics Corp

This filing details a disposition of 10 shares of Common Stock by Andrew J. Schwab, a director at Camp4 Therapeutics Corp, on August 24, 2026. The transaction occurred at a price of $4.50 per share. Following this transaction, the total number of shares held by 5AM Ventures VII, L.P. is 2,941,176, and the total number of shares held by 5AM Opportunities II, L.P. is 302,770. The filing also notes that Andrew J. Schwab, as a managing member of the general partners of these entities, may be deemed to have shared voting and investment power over these shares, though he disclaims beneficial ownership except to the extent of his pecuniary interest.